<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 3.2 Final//EN">
<HTML>
<HEAD>
     <!-- Created by EDGAR Ease Plus (EDGAR Ease+ 1.1a) -->
     <!-- Project:        I:\CONVER\NY13539.eep -->
     <!-- Filing Type:    8k                                                                 -->
     <!-- Client Name:    Advanced Medical Optics                                                           -->
     <!-- Project Name:   NY13539                          -->
     <TITLE>8K Form</TITLE>
</HEAD>
<BODY><BR><BR>

<!-- MARKER FORMAT-SHEET="Page Break Table" FSL="Project" -->
<TABLE WIDTH=600 CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR VALIGN=TOP>
<TD><HR SIZE=5 NOSHADE COLOR="BLACK">
</TD></TR></TABLE><BR>
<BR>


<!-- MARKER FORMAT-SHEET="Head Center Bold 2 600" FSL="Project" -->
<TABLE WIDTH=600 CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR VALIGN=TOP>
<TD><H1 ALIGN=CENTER><FONT FACE="Times New Roman, Times, Serif" SIZE=2> UNITED
STATES <BR>SECURITIES AND EXCHANGE COMMISSION<BR>Washington, D.C. 20549 </FONT></H1></TD></TR>
</TABLE>
<BR>




<!-- MARKER FORMAT-SHEET="Head Center 2 600" FSL="Project" -->
<TABLE WIDTH=600 CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR VALIGN=BOTTOM>
<TD ALIGN=CENTER><FONT FACE="Times New Roman, Times, Serif" SIZE=3><B>FORM 8-K</B></FONT></TD></TR>
</TABLE>
<BR>

<!-- MARKER FORMAT-SHEET="Head Center 2 600" FSL="Project" -->
<TABLE WIDTH=600 CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR VALIGN=BOTTOM>
<TD ALIGN=CENTER><FONT FACE="Times New Roman, Times, Serif" SIZE=2><B>CURRENT REPORT
<BR>Pursuant to Section 13 or 15(d) of the<BR> Securities Exchange Act of 1934</B>  </FONT></TD></TR>
</TABLE>
<BR> <BR>




<!-- MARKER FORMAT-SHEET="Head Center 2 600" FSL="Project" -->
<TABLE WIDTH=600 CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR VALIGN=TOP>
<TD ALIGN=CENTER><FONT FACE="Times New Roman, Times, Serif" SIZE=2>Date
of Report (Date of earliest event reported):&nbsp;<B>November 9. 2004</B>  </FONT></TD></TR>
</TABLE>
<BR>



<TABLE WIDTH="600" BORDER="0" CELLPADDING="0" CELLSPACING="0">
<TR VALIGN="BOTTOM">
     <TD WIDTH="600" ALIGN="CENTER"><FONT FACE="Times New Roman, Times, Serif" SIZE="4"><B> ADVANCED MEDICAL OPTICS, INC.</B></FONT></TD></TR>
<TR VALIGN="MIDDLE">
     <TD WIDTH="600" ALIGN="CENTER"><HR NOSHADE SIZE=1 WIDTH=100%></TD></TR>
<TR VALIGN="TOP">
     <TD WIDTH="600" ALIGN="CENTER"><FONT FACE="Times New Roman, Times, Serif" SIZE="2">(Exact name of registrant as specified in its charter)</FONT></TD></TR>
</TABLE>
<BR><BR>

<!-- MARKER FORMAT-SHEET="8k Cover table 3" FSL="Project" -->
<TABLE WIDTH="600" CELLPADDING="0" CELLSPACING="0" BORDER="0">
<TR Valign=BOTTOM>
<TD WIDTH="33%" ALIGN="CENTER"><FONT FACE="Times New Roman, Times, Serif" SIZE=2><B>Delaware</B></FONT></TD>
<TD WIDTH="34%" ALIGN="CENTER"><FONT FACE="Times New Roman, Times, Serif" SIZE=2> <B>001-31257</B></FONT></TD>
<TD WIDTH="33%" ALIGN="CENTER"><FONT FACE="Times New Roman, Times, Serif" SIZE=2><B>33-0986820</B></FONT></TD>
</TR>
<TR VALIGN=TOP>
<TD ALIGN="CENTER"><HR SIZE=1 NOSHADE></TD>
<td ALIGN=CENTER><HR SIZE=1 NOSHADE></TD>
<TD ALIGN="CENTER"><HR SIZE=1 NOSHADE></TD>
</TR>
<TR VALIGN=TOP>
<TD ALIGN="CENTER"><Font Face="Times New Roman, Times, Serif" Size=2>(State or other jurisdiction <BR>of incorporation)</font></td>
<TD ALIGN="CENTER"><Font Face="Times New Roman, Times, Serif" Size=2>(Commission<BR>File Number) </FONT></TD>
<TD ALIGN="CENTER"><Font Face="Times New Roman, Times, Serif" Size=2>(IRS Employer<BR> Identification No.) </FONT></TD>
</TR>
</TABLE>
<BR>

<TABLE WIDTH="600" BORDER="0" CELLPADDING="0" CELLSPACING="0">
<TR VALIGN="BOTTOM">
     <TD WIDTH="70%" ALIGN="CENTER"><FONT FACE="Times New Roman, Times, Serif" SIZE="2">
<B>1700 E. St. Andrew Place <BR>
     Santa Ana, CA  </B>
<!-- ADDRESS --></FONT></TD>
     <TD WIDTH="10%"><FONT FACE="Times New Roman, Times, Serif" SIZE="2">&nbsp;</FONT></TD>
     <TD WIDTH="20%"><FONT FACE="Times New Roman, Times, Serif" SIZE="2"><B>92705</B><!-- ZIP CODE --></FONT></TD></TR>
<TR VALIGN="TOP">
     <TD><HR NOSHADE SIZE=1></TD>
     <TD><HR NOSHADE SIZE=1></TD>
     <TD><HR NOSHADE SIZE=1></TD></TR>
<TR VALIGN="TOP">
     <TD ALIGN="CENTER"><FONT FACE="Times New Roman, Times, Serif" SIZE="2">(Address of principal executive offices)</FONT></TD>
     <TD><FONT FACE="Times New Roman, Times, Serif" SIZE="2">&nbsp;</FONT></TD>
     <TD><FONT FACE="Times New Roman, Times, Serif" SIZE="2">(Zip Code)</FONT></TD></TR>
</TABLE>
<BR>

<TABLE WIDTH="600" BORDER="0" CELLPADDING="0" CELLSPACING="0">
<TR VALIGN="BOTTOM">
     <TD WIDTH="49%"><FONT FACE="Times New Roman, Times, Serif" SIZE="2">Registrant's telephone number, including area code:</FONT></TD>
     <TD WIDTH="31%"><FONT FACE="Times New Roman, Times, Serif" SIZE="2">&nbsp;&nbsp;<B>(714) 247-8200</B></FONT></TD>
     <TD WIDTH="20%"><FONT FACE="Times New Roman, Times, Serif" SIZE="2"><!-- TELEPHONE NO. --></FONT></TD></TR>
<TR VALIGN="TOP">
     <TD>&nbsp;</TD>
     <TD><HR NOSHADE SIZE=1></TD>
     <TD><HR NOSHADE SIZE=1></TD></TR>
</TABLE>
<BR>

<TABLE WIDTH="600" BORDER="0" CELLPADDING="0" CELLSPACING="0">
<TR VALIGN="BOTTOM">
     <TD WIDTH="600" ALIGN="CENTER"><FONT FACE="Times New Roman, Times, Serif" SIZE="2">&nbsp;<!-- FORMER NAME OR ADDRESS --></FONT></TD></TR>
<TR VALIGN="MIDDLE">
     <TD WIDTH="600" ALIGN="CENTER"><HR NOSHADE SIZE=1></TD></TR>
<TR VALIGN="TOP">
     <TD WIDTH="600" ALIGN="CENTER"><FONT FACE="Times New Roman, Times, Serif" SIZE="2">(Former name or former address, if changed since last report) </FONT></TD></TR>
</TABLE><BR><BR>



<!-- MARKER FORMAT-SHEET="Para Flush Left" FSL="Default" -->
<TABLE WIDTH=600 CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR VALIGN=TOP>
<TD><FONT FACE="Times New Roman, Times, Serif" SIZE=2>Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the
filing obligation of the registrant under any of the following provisions (see General
Instruction A.2. below): </FONT></TD></TR></TABLE><BR>

<!-- MARKER FORMAT-SHEET="Para List Hang" FSL="Project" -->
<TABLE WIDTH=600 CELLPADDING=0 CELLSPACING=0 BORDER=0>
<TR VALIGN=TOP>
<TD WIDTH=4%><font face="wingdings"> &#120;</font></TD>
<TD WIDTH=96%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
 Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) </FONT></TD>
</TR>
</TABLE>
<BR>

<!-- MARKER FORMAT-SHEET="Para List Hang" FSL="Project" -->
<TABLE WIDTH=600 CELLPADDING=0 CELLSPACING=0 BORDER=0>
<TR VALIGN=TOP>
<TD WIDTH=4%><font face="wingdings"> &#168; </font></TD>
<TD WIDTH=96%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
 Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) </FONT></TD>
</TR>
</TABLE>
<BR>

<!-- MARKER FORMAT-SHEET="Para List Hang" FSL="Project" -->
<TABLE WIDTH=610 CELLPADDING=0 CELLSPACING=0 BORDER=0>
<TR VALIGN=TOP>
<TD WIDTH=4%><font face="wingdings"> &#168; </font></TD>
<TD WIDTH=96%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
 Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b)) </FONT></TD>
</TR>
</TABLE>
<BR>

<!-- MARKER FORMAT-SHEET="Para List Hang" FSL="Project" -->
<TABLE WIDTH=610 CELLPADDING=0 CELLSPACING=0 BORDER=0>
<TR VALIGN=TOP>
<TD WIDTH=4%><font face="wingdings"> &#168; </font></TD>
<TD WIDTH=96%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
 Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c)) </FONT></TD>
</TR>
</TABLE>
<BR>


<!-- MARKER FORMAT-SHEET="Page Break Table" FSL="Project" -->
<TABLE WIDTH=605 CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR VALIGN=TOP>
<TD><HR SIZE=5 NOSHADE COLOR="BLACK">
<BR></TD></TR></TABLE>
<BR>




<!-- MARKER FORMAT-SHEET="Para Flush Left" FSL="Project" -->
<TABLE WIDTH=600 CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR VALIGN=TOP>
<TD><FONT FACE="Times New Roman, Times, Serif" SIZE=2><b>Item
1.01. &nbsp;&nbsp;Entry into a Material Definitive Agreement</b><BR><BR>On
November 9, 2004, Advanced Medical Optics, Inc., a Delaware corporation (&#147;AMO&#148;),
Vault Merger Corporation (&#147;Merger Sub&#148;), a wholly owned subsidiary of AMO and a
Delaware corporation, and VISX, Incorporated, a Delaware corporation (&#147;VISX&#148;),
entered into an Agreement and Plan of Merger (the &#147;Merger Agreement&#148;), as
announced in the attached joint press release dated November 9, 2004. Pursuant to the
terms and subject to the conditions set forth in the Merger Agreement, Merger Sub will
merge with and into VISX, with VISX continuing as the surviving corporation and becoming a
wholly owned subsidiary of AMO (the &#147;Merger&#148;). The Board of Directors of AMO has
unanimously approved the Merger and the Merger Agreement and recommended that the AMO
stockholders approve the issuance of shares of AMO common stock in the Merger. </FONT></TD></TR></TABLE><BR>

<!-- MARKER FORMAT-SHEET="Para Flush Left" FSL="Project" -->
<TABLE WIDTH=600 CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR VALIGN=TOP>
<TD><FONT FACE="Times New Roman, Times, Serif" SIZE=2>In
connection with the Merger, each share of VISX common stock that is outstanding at the
effective time of the Merger (the &#147;Effective Time&#148;) will be converted into the
right to receive (i) 0.552 shares of common stock of AMO, and (ii) $3.50 in cash without
interest (the &#147;Merger Consideration&#148;). Each outstanding option to purchase VISX
common stock (a &#147;VISX Stock Option&#148;) that has an exercise price equal to or less
than $26.93 will be converted at the Effective Time into an option to acquire AMO common
stock and shall become fully vested and immediately exercisable and assumed by AMO. Each
VISX Stock Option that has an exercise price in excess of $26.93 shall become fully vested
and immediately exercisable at the Effective Time, and the holder of each such option will
be notified that if such options are not exercised within 15 days (30 days for options
granted under VISX&#146;s 1995 Director Option and Stock Deferral Plan), such options will
expire and be of no further force or effect. No fractional shares of AMO&#146;s common
stock will be issued as a result of the share exchange. </FONT></TD></TR></TABLE><BR>

<!-- MARKER FORMAT-SHEET="Para Flush Left" FSL="Project" -->
<TABLE WIDTH=600 CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR VALIGN=TOP>
<TD><FONT FACE="Times New Roman, Times, Serif" SIZE=2>At
November 4, 2004, there were 49,610,200 shares of VISX common stock outstanding. At
November 4, 2004, there were outstanding options to purchase 8,425,399 shares of VISX
common stock. Of these options, approximately 7,340,849 are expected to be converted into
options to acquire AMO&#146;s common stock at the Effective Time of the Merger. </FONT></TD></TR></TABLE><BR>

<!-- MARKER FORMAT-SHEET="Para Flush Left" FSL="Project" -->
<TABLE WIDTH=600 CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR VALIGN=TOP>
<TD><FONT FACE="Times New Roman, Times, Serif" SIZE=2>The
completion of the Merger is subject to various customary conditions, including obtaining
the approval of the AMO and VISX stockholders and expiration of the applicable waiting
period under the Hart-Scott-Rodino Act. The Merger is intended to qualify as a
reorganization for federal income tax purposes. In connection with the financing for the
Merger, AMO has signed a commitment letter, dated November 9, 2004, with Morgan Stanley
&amp; Co. Incorporated. </FONT></TD></TR></TABLE><BR>

<!-- MARKER FORMAT-SHEET="Para Flush Left" FSL="Default" -->
<TABLE WIDTH=600 CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR VALIGN=TOP>
<TD><FONT FACE="Times New Roman, Times, Serif" SIZE=2>The
information set forth above does not purport to be complete and is qualified in its
entirety by reference to the full text of the Merger Agreement, a copy of which is filed
herewith as Exhibit 2.1, and is incorporated herein by reference. A copy of the joint
press release is attached to this Current Report as Exhibit 99.1 and is incorporated
herein by reference. </FONT></TD></TR></TABLE><BR>



<!-- MARKER FORMAT-SHEET="Page Break Table" FSL="Project" -->
<TABLE WIDTH=605 CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR VALIGN=TOP>
<TD><HR SIZE=5 NOSHADE COLOR="BLACK">
<BR></TD></TR></TABLE>
<BR>




<!-- MARKER FORMAT-SHEET="Head Left Bold 2 600" FSL="Project" -->
<TABLE WIDTH=600 CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR VALIGN=TOP>
<TD>
<H1 ALIGN=LEFT><FONT FACE="Times New Roman, Times, Serif" SIZE=2>Item 9.01. Financial Statements and Exhibits.</FONT></H1></TD></TR>
</TABLE>
<BR>

<!-- MARKER FORMAT-SHEET="Head Left Bold 2 600" FSL="Default" -->
<TABLE WIDTH=600 CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR VALIGN=TOP>
<TD>
<H1 ALIGN=LEFT><FONT FACE="Times New Roman, Times, Serif" SIZE=2>(c)
Exhibits.</FONT></H1></TD></TR>
</TABLE>
<BR>



<!-- MARKER FORMAT-SHEET="Reg Cover Table 2 Col" FSL="Project" -->
<TABLE WIDTH=600 CELLPADDING=0 CELLSPACING=0 BORDER=0>
<TR VALIGN=TOP>
<Th ALIGN=left WIDTH=20%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>Exhibit No.</FONT></Th>
<Th ALIGN=left WIDTH=80%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>Description</FONT></Th>
</TR>
<TR VALIGN=TOP>
<Th><FONT FACE="Times New Roman, Times, Serif" SIZE=2>&nbsp;</FONT></Th>
<Th><FONT FACE="Times New Roman, Times, Serif" SIZE=2>&nbsp;</FONT></Th>
</TR>

<TR VALIGN=TOP>
<TD ALIGN=left><FONT FACE="Times New Roman, Times, Serif" SIZE=2>2.1</FONT></TD>
<TD ALIGN=left><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
Agreement and Plan of Merger, dated as of November 9, 2004, by and among Advanced Medical
Optics, Inc., Vault Merger Corporation, a wholly owned subsidiary of AMO, and VISX, Incorporated
(the schedules have been omitted pursuant to Item 601(b)(2) of Regulation S-K and will be
provided to the Securities and Exchange Commission upon request).
 </FONT></TD></TR>

<TR VALIGN=TOP>
<TD ALIGN=left><FONT FACE="Times New Roman, Times, Serif" SIZE=2>99.1</FONT></TD>
<TD ALIGN=left><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
Joint Press release issued by Advanced Medical Optics, Inc. and VISX, Incorporated dated
               November 9, 2004.
</FONT></TD></TR>
</TABLE>
<BR>




<!-- MARKER FORMAT-SHEET="Page Break Table" FSL="Project" -->
<TABLE WIDTH=600 CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR VALIGN=TOP>
<TD><HR SIZE=5 NOSHADE COLOR="BLACK">
</TD></TR></TABLE><BR>
<BR>

<!-- MARKER FORMAT-SHEET="Head Center Bold 2 600" FSL="Project" -->
<TABLE WIDTH=600 CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR VALIGN=TOP>
<TD><H1 ALIGN=CENTER><FONT FACE="Times New Roman, Times, Serif" SIZE=2>SIGNATURES </FONT></H1></TD></TR>
</TABLE>
<BR>

<!-- MARKER FORMAT-SHEET="Para Indent 0" FSL="Default" -->
<TABLE WIDTH=600 CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR VALIGN=TOP>
<TD><FONT FACE="Times New Roman, Times, Serif" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused
this report to be signed on its behalf by the undersigned hereunto duly authorized. </FONT></TD></TR>
</TABLE>
<BR>



<!-- MARKER FORMAT-SHEET="Company Right" FSL="Project" -->
<TABLE WIDTH="600" BORDER="0" CELLSPACING="0" CELLPADDING="0">
  <TR VALIGN="BOTTOM">
    <TD WIDTH="8%"><FONT FACE="Times New Roman, Times, Serif" SIZE="2">&nbsp; <!-- TYPE "DATE:" HERE--> </FONT></TD>
    <TD WIDTH="44%"><FONT FACE="Times New Roman, Times, Serif" SIZE="2">&nbsp; </FONT></TD>
    <TD WIDTH="48%"><FONT FACE="Times New Roman, Times, Serif" SIZE="2">ADVANCED MEDICAL OPTICS, INC.</FONT></TD>
  </TR>
</TABLE>
<BR>
<!-- MARKER FORMAT-SHEET="Date By Signature" FSL="Project" -->
<TABLE WIDTH="600" BORDER="0" CELLSPACING="0" CELLPADDING="0">
  <TR VALIGN="BOTTOM">
    <TD WIDTH="8%"><FONT FACE="Times New Roman, Times, Serif" SIZE="2"> &nbsp; </FONT></TD>
    <TD WIDTH="39%"><FONT FACE="Times New Roman, Times, Serif" SIZE="2">&nbsp; <!-- DATE--> </FONT></TD>
    <TD WIDTH="5%"><FONT FACE="Times New Roman, Times, Serif" SIZE="2">&nbsp; </FONT></TD>
    <TD WIDTH="5%"><FONT FACE="Times New Roman, Times, Serif" SIZE="2">By: </FONT></TD>
    <TD WIDTH="43%"><FONT FACE="Times New Roman, Times, Serif" SIZE="2">&nbsp;/s/ Aimee S. Weisner </FONT></TD>
  </TR>
  <TR VALIGN="TOP">
    <TD><FONT FACE="Times New Roman, Times, Serif" SIZE="2">&nbsp; </FONT></TD>
    <TD>&nbsp; </TD>
    <TD><FONT FACE="Times New Roman, Times, Serif" SIZE="2">&nbsp; </FONT></TD>
    <TD><FONT FACE="Times New Roman, Times, Serif" SIZE="2">&nbsp; </FONT></TD>
    <TD> <HR NOSHADE SIZE="1"> </TD>
  </TR>
</TABLE>
<!-- MARKER FORMAT-SHEET="Name Title Right" FSL="Project" -->
<TABLE WIDTH="600" BORDER="0" CELLSPACING="0" CELLPADDING="0">
  <TR VALIGN="TOP">
    <TD WIDTH="57%"><FONT FACE="Times New Roman, Times, Serif" SIZE="2">&nbsp; </FONT></TD>
    <TD WIDTH="35%"><FONT FACE="Times New Roman, Times, Serif" SIZE="2">  Aimee S. Weisner</FONT></TD>
    <TD WIDTH="8%"><FONT FACE="Times New Roman, Times, Serif" SIZE="2"> </FONT></TD>
</TR>

  <TR VALIGN="TOP">
    <TD WIDTH="57%"><FONT FACE="Times New Roman, Times, Serif" SIZE="2">&nbsp; </FONT></TD>
    <TD WIDTH="35%" VALIGN="TOP"><FONT FACE="Times New Roman, Times, Serif" SIZE="2">
Corporate Vice President, General Counsel and
Secretary</FONT></TD>
    <TD WIDTH="8%"><FONT FACE="Times New Roman, Times, Serif" SIZE="2"> </FONT></TD>
 </tr>
</TABLE>
<BR>

<!-- MARKER FORMAT-SHEET="Para Flush Left" FSL="Project" -->
<TABLE WIDTH=600 CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR VALIGN=TOP>
<TD><FONT FACE="Times New Roman, Times, Serif" SIZE=2>Date:&nbsp; November 10, 2004 </FONT></TD></TR></TABLE><BR>




<!-- MARKER FORMAT-SHEET="Page Break Table" FSL="Project" -->
<TABLE WIDTH=600 CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR VALIGN=TOP>
<TD><HR SIZE=5 NOSHADE COLOR="BLACK">
</TD></TR></TABLE><BR>
<BR>
<BR>

<!-- MARKER FORMAT-SHEET="Head Center Bold 2 600" FSL="Default" -->
<TABLE WIDTH=600 CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR VALIGN=TOP>
<TD><H1 ALIGN=CENTER><FONT FACE="Times New Roman, Times, Serif" SIZE=2>EXHIBIT INDEX </FONT></H1></TD></TR>
</TABLE>
<BR>



<!-- MARKER FORMAT-SHEET="Reg Cover Table 2 Col" FSL="Project" -->
<TABLE WIDTH=600 CELLPADDING=0 CELLSPACING=0 BORDER=0>
<TR VALIGN=TOP>
<Th ALIGN=left WIDTH=20%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>Exhibit No.</FONT></Th>
<Th ALIGN=left WIDTH=80%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>Description</FONT></Th>
</TR>
<TR VALIGN=TOP>
<Th><FONT FACE="Times New Roman, Times, Serif" SIZE=2>&nbsp;</FONT></Th>
<Th><FONT FACE="Times New Roman, Times, Serif" SIZE=2>&nbsp;</FONT></Th>
</TR>

<TR VALIGN=TOP>
<TD ALIGN=left><FONT FACE="Times New Roman, Times, Serif" SIZE=2>2.1</FONT></TD>
<TD ALIGN=left><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
Agreement and Plan of Merger, dated as of November 9, 2004, by and among Advanced Medical
Optics, Inc., Vault Merger Corporation, a wholly owned subsidiary of AMO, and VISX, Incorporated
(the schedules have been omitted pursuant to Item 601(b)(2) of Regulation S-K and will be
provided to the Securities and Exchange Commission upon request).
 </FONT></TD></TR>

<TR VALIGN=TOP>
<TD ALIGN=left><FONT FACE="Times New Roman, Times, Serif" SIZE=2>99.1</FONT></TD>
<TD ALIGN=left><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
Joint Press release issued by Advanced Medical Optics, Inc. and VISX, Incorporated dated
               November 9, 2004.

</FONT></TD></TR>
</TABLE>



</BODY>
</HTML>
[{"type": "8-K", "sequence": "1", "filename": "la377425.htm", "description": "FORM 8-K", "secsgml_size_bytes": 19474}]
{"company-data": {"conformed-name": "ADVANCED MEDICAL OPTICS INC", "cik": "0001168335", "assigned-sic": "3841", "irs-number": "330986820", "state-of-incorporation": "DE"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "001-31257", "film-number": "041134026"}, "business-address": {"street1": "1700 E. ST. ANDREW PL.", "city": "SANTA ANA", "state": "CA", "zip": "92705", "phone": "714-247-8200"}}
8K Form
UNITED
STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported):
November 9. 2004
ADVANCED MEDICAL OPTICS, INC.
(Exact name of registrant as specified in its charter)
Delaware
001-31257
33-0986820
(State or other jurisdiction
of incorporation)
(Commission
File Number)
(IRS Employer
Identification No.)
1700 E. St. Andrew Place
Santa Ana, CA
92705
(Address of principal executive offices)
(Zip Code)
Registrant's telephone number, including area code:
(714) 247-8200
(Former name or former address, if changed since last report)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the
filing obligation of the registrant under any of the following provisions (see General
Instruction A.2. below):
x
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
¨
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
Item
1.01.   Entry into a Material Definitive Agreement
On
November 9, 2004, Advanced Medical Optics, Inc., a Delaware corporation ("AMO"),
Vault Merger Corporation ("Merger Sub"), a wholly owned subsidiary of AMO and a
Delaware corporation, and VISX, Incorporated, a Delaware corporation ("VISX"),
entered into an Agreement and Plan of Merger (the "Merger Agreement"), as
announced in the attached joint press release dated November 9, 2004. Pursuant to the
terms and subject to the conditions set forth in the Merger Agreement, Merger Sub will
merge with and into VISX, with VISX continuing as the surviving corporation and becoming a
wholly owned subsidiary of AMO (the "Merger"). The Board of Directors of AMO has
unanimously approved the Merger and the Merger Agreement and recommended that the AMO
stockholders approve the issuance of shares of AMO common stock in the Merger.
In
connection with the Merger, each share of VISX common stock that is outstanding at the
effective time of the Merger (the "Effective Time") will be converted into the
right to receive (i) 0.552 shares of common stock of AMO, and (ii) $3.50 in cash without
interest (the "Merger Consideration"). Each outstanding option to purchase VISX
common stock (a "VISX Stock Option") that has an exercise price equal to or less
than $26.93 will be converted at the Effective Time into an option to acquire AMO common
stock and shall become fully vested and immediately exercisable and assumed by AMO. Each
VISX Stock Option that has an exercise price in excess of $26.93 shall become fully vested
and immediately exercisable at the Effective Time, and the holder of each such option will
be notified that if such options are not exercised within 15 days (30 days for options
granted under VISX's 1995 Director Option and Stock Deferral Plan), such options will
expire and be of no further force or effect. No fractional shares of AMO's common
stock will be issued as a result of the share exchange.
At
November 4, 2004, there were 49,610,200 shares of VISX common stock outstanding. At
November 4, 2004, there were outstanding options to purchase 8,425,399 shares of VISX
common stock. Of these options, approximately 7,340,849 are expected to be converted into
options to acquire AMO's common stock at the Effective Time of the Merger.
The
completion of the Merger is subject to various customary conditions, including obtaining
the approval of the AMO and VISX stockholders and expiration of the applicable waiting
period under the Hart-Scott-Rodino Act. The Merger is intended to qualify as a
reorganization for federal income tax purposes. In connection with the financing for the
Merger, AMO has signed a commitment letter, dated November 9, 2004, with Morgan Stanley
& Co. Incorporated.
The
information set forth above does not purport to be complete and is qualified in its
entirety by reference to the full text of the Merger Agreement, a copy of which is filed
herewith as Exhibit 2.1, and is incorporated herein by reference. A copy of the joint
press release is attached to this Current Report as Exhibit 99.1 and is incorporated
herein by reference.
Item 9.01. Financial Statements and Exhibits.
(c)
Exhibits.
Exhibit No.
Description
2.1
Agreement and Plan of Merger, dated as of November 9, 2004, by and among Advanced Medical
Optics, Inc., Vault Merger Corporation, a wholly owned subsidiary of AMO, and VISX, Incorporated
(the schedules have been omitted pursuant to Item 601(b)(2) of Regulation S-K and will be
provided to the Securities and Exchange Commission upon request).
99.1
Joint Press release issued by Advanced Medical Optics, Inc. and VISX, Incorporated dated
               November 9, 2004.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused
this report to be signed on its behalf by the undersigned hereunto duly authorized.
ADVANCED MEDICAL OPTICS, INC.
By:
/s/ Aimee S. Weisner
Aimee S. Weisner
Corporate Vice President, General Counsel and
Secretary
Date:  November 10, 2004
EXHIBIT INDEX
Exhibit No.
Description
2.1
Agreement and Plan of Merger, dated as of November 9, 2004, by and among Advanced Medical
Optics, Inc., Vault Merger Corporation, a wholly owned subsidiary of AMO, and VISX, Incorporated
(the schedules have been omitted pursuant to Item 601(b)(2) of Regulation S-K and will be
provided to the Securities and Exchange Commission upon request).
99.1
Joint Press release issued by Advanced Medical Optics, Inc. and VISX, Incorporated dated
               November 9, 2004.